You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-MET (MET) Antibodies

Full name:
anti-Met Proto-Oncogene Antibodies (MET)
On www.antibodies-online.com are 694 Met Proto-Oncogene (MET) Antibodies from 31 different suppliers available. Additionally we are shipping MET Kits (61) and MET Proteins (52) and many more products for this protein. A total of 833 MET products are currently listed.
Synonyms:
AI838057, AUTS9, c-met, HGF, Hgfr, Par4, RCCP2
list all antibodies Gene Name GeneID UniProt
MET 4233 P08581
MET 17295  
MET 24553 P97523

Show all species

Show all synonyms

All available anti-MET Antibodies

Go to our pre-filtered search.

Top referenced anti-MET Antibodies

  1. Human Monoclonal MET Primary Antibody for FACS, IHC (p) - ABIN1688523 : Zagouri, Bago-Horvath, Rössler, Brandstetter, Bartsch, Papadimitriou, Dimitrakakis, Tsigginou, Papaspyrou, Giannos, Dimopoulos, Filipits: High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer. in British journal of cancer 2013 (PubMed)
    Show all 36 references for ABIN1688523

  2. Human Polyclonal MET Primary Antibody for EIA, WB - ABIN358165 : Wong, Roskelley, Pelech, Miller, Leung, Auersperg: Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation. in Experimental cell research 2004 (PubMed)
    Show all 5 references for ABIN358165

  3. Human Polyclonal MET Primary Antibody for EIA, IHC (p) - ABIN358164 : Mineo, Costantino, Frasca, Sciacca, Russo, Vigneri, Belfiore: Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels. in Endocrinology 2004 (PubMed)
    Show all 5 references for ABIN358164

  4. Human Monoclonal MET Primary Antibody for FACS - ABIN4896926 : Tervonen, Belitškin, Pant, Englund, Marques, Ala-Hongisto, Nevalaita, Sihto, Heikkilä, Leidenius, Hewitson, Ramachandra, Moilanen, Joensuu, Kovanen, Poso, Klefström: Deregulated hepsin protease activity confers oncogenicity by concomitantly augmenting HGF/MET signalling and disrupting epithelial cohesion. in Oncogene 2016 (PubMed)
    Show all 3 references for ABIN4896926

  5. Human Polyclonal MET Primary Antibody for EIA, WB - ABIN401382 : Fan, Ma, Gao, Yuan, Meng, Goldberg, Rosen: The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair. in Molecular and cellular biology 2001 (PubMed)
    Show all 3 references for ABIN401382

  6. Human Polyclonal MET Primary Antibody for IF, ELISA - ABIN1533596 : Hillier, Fulton, Fulton, Graves, Pepin, Wagner-McPherson, Layman, Maas, Jaeger, Walker, Wylie, Sekhon, Becker, OLaughlin, Schaller, Fewell, Delehaunty, Miner, Nash, Cordes, Du, Sun, Edwards et al.: The DNA sequence of human chromosome 7. ... in Nature 2003 (PubMed)
    Show all 2 references for ABIN1533596

  7. Human Monoclonal MET Primary Antibody for FACS - ABIN4896921 : Baccelli, Schneeweiss, Riethdorf, Stenzinger, Schillert, Vogel, Klein, Saini, Bäuerle, Wallwiener, Holland-Letz, Höfner, Sprick, Scharpff, Marmé, Sinn, Pantel, Weichert, Trumpp: Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. in Nature biotechnology 2013 (PubMed)
    Show all 2 references for ABIN4896921

  8. Human Polyclonal MET Primary Antibody for IHC (p), WB - ABIN389595 : Guo, Prins, Dang, Kuga, Iwanami, Soto, Lin, Huang, Akhavan, Hock, Zhu, Kofman, Bensinger, Yong, Vinters, Horvath, Watson, Kuhn, Robins, Mehta, Wen, DeAngelis, Prados, Mellinghoff, Cloughesy, Mischel: EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. in Science signaling 2009 (PubMed)
    Show all 2 references for ABIN389595

  9. Human Monoclonal MET Primary Antibody for FACS - ABIN4896923 : Sie, den Dunnen, Lourens, Meeuwsen-de Boer, Scherpen, Zomerman, Kampen, Hoving, de Bont: Growth-factor-driven rescue to receptor tyrosine kinase (RTK) inhibitors through Akt and Erk phosphorylation in pediatric low grade astrocytoma and ependymoma. in PLoS ONE 2015 (PubMed)

  10. Human Polyclonal MET Primary Antibody for DB - ABIN389596 : Xu, Xia, Baker, Zhou, Cha, Voorhees, Fisher: Receptor-type protein tyrosine phosphatase beta (RPTP-beta) directly dephosphorylates and regulates hepatocyte growth factor receptor (HGFR/Met) function. in The Journal of biological chemistry 2011 (PubMed)

More Antibodies against MET Interaction Partners

Human Met Proto-Oncogene (MET) interaction partners

  1. his review will describe the mechanisms of aberrant c-Met signaling in colorectal cancer and discuss on additional roles for c-Met receptor through crosstalk with other tyrosine kinase (show TXK Antibodies) receptors and cell surface proteins in colorectal cancer

  2. This article reviews aberrations in epidermal growth factor receptor (show EGFR Antibodies), MET, and ERBB2 (show ERBB2 Antibodies), their therapeutic implications, and future directions in targeting these pathways.

  3. This review highlights treatment options, including clinical trials for ROS1 rearrangement, RET fusions, NTRK1 fusions, MET exon skipping, BRAF mutations, and KRAS mutations.

  4. MET amplification and overexpression, assessed by multiple methods, were associated with a worse prognosis in univariate analyses. However, only MET amplification by FISH and Met expression by SRM (show SRM Antibodies) were independent prognostic biomarkers.

  5. AZD9291 is the first and only FDA approved third-generation epidermal growth factor receptor (EGFR (show EGFR Antibodies)) tyrosine kinase (show TXK Antibodies) inhibitors for T790M-positive advanced non-small cell patients. The resistance to AZD9291 arises after therapy. The mechanisms of resistance to third-generation inhibitors reported to date include the EGFR (show EGFR Antibodies) C797S mutation, EGFR (show EGFR Antibodies) L718Q mutation, and amplifications of HER-2 (show ERBB2 Antibodies), MET, or ERBB2 (show ERBB2 Antibodies). [review]

  6. study indicates that tyrosine kinase (show TXK Antibodies) signaling in host pre-osteoclasts/osteoclasts is critical for bone destruction induced by tumor cells and that targeting of MET/VEGF receptor (show FLT1 Antibodies)/FMS (show CSF1R Antibodies) activity makes it a promising therapeutic candidate for the treatment of prostate cancer patients with bone metastasis.

  7. Data identify, for the first time, a novel non-canonical dynamic mode of interaction between Met and the p66 (show POLD3 Antibodies) protein isoform of Shc (show SHC1 Antibodies) and its effects on rewiring binding effector complexes according to the activation state of the receptor.

  8. Specifically, miR (show MLXIP Antibodies)-130a was attenuated in HFD-induced PCa (show FLVCR1 Antibodies) progression with MET overexpression. miRNAs thus have implications in the mechanism, prevention and treatment of HFD-induced prostate cancer (PCa (show FLVCR1 Antibodies))progression.

  9. We observed that TKI-resistant cells have increased gene and protein expression of EMT (show ITK Antibodies) related proteins such as Vimentin (show VIM Antibodies), N-Cadherin (show CDH2 Antibodies), beta-Catenin (show CTNNB1 Antibodies) and Zeb-1 (show ZEB1 Antibodies), while expression of E-Cadherin (show CDH1 Antibodies), an important cell adhesion molecule (show MCAM Antibodies), was suppressed.

  10. PD-L1 expression is positively correlated with c-Met expression in esophageal squamous cell carcinoma

Mouse (Murine) Met Proto-Oncogene (MET) interaction partners

  1. In this paper, we demonstrate a potential biochemical mechanism for such phenomena by showing that c-Met receptors promote the tyrosine phosphorylation of RalGDS (show RALGDS Antibodies) at Y752 in its RBD (show CACNA1D Antibodies), which blocks the binding of Ras to RalGDS (show RALGDS Antibodies).

  2. study demonstrates that co-activation of AKT (show AKT1 Antibodies) and c-Met induces hepatocellular carcinoma development that depends on the mTORC1/FASN (show FASN Antibodies) pathway.

  3. Molecular and functional studies revealed that ectopic Met expression in limb mesenchyme does not alter HGF (show HGF Antibodies) expression patterns and levels, but impairs HGF (show HGF Antibodies) bioavailability

  4. miR-206 suppressed c-Met expression in gastric cancer and could function as a potent tumor suppressor in c-Met overexpressing tumors.

  5. Meg3 overexpression in insulinoma cells down-regulated the expression of the protooncogene c-met.

  6. our results support the concept of the acrosome as a lysosome-related organelle and provide evidence for the identification of MET as a tyrosine kinase receptor (show KDR Antibodies) that may play a role in fertilization.

  7. We show that a subset of adult calcitonin gene-related peptide (CGRP (show CALCA Antibodies))-expressing myenteric neurons produce MET, the receptor for hepatocyte growth factor (show HGF Antibodies).

  8. HGF and c-met inhibition by means of a novel monoclonal neutralizing antibody inhibits tumor growth in prostate cancer cells and in mouse xenografts.

  9. facilitates T cell recruitment to the heart via CCR5 (show CCR5 Antibodies) receptor by inducing autocrine CCR5 (show CCR5 Antibodies) ligand release

  10. C-Met pathway is suggested to contribute to the lymphomagenesis in the MALT lymphoma after H. heilmannii infection.

Cow (Bovine) Met Proto-Oncogene (MET) interaction partners

  1. possible cooperative role of the EGF (show EGF Antibodies) and HGF (show HGF Antibodies) pathways and indicate that cross-talk between their respective receptors may modulate mammary gland development in the cow

MET Antigen Profile

Antigen Summary

The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. Various mutations in the MET gene are associated with papillary renal carcinoma. Two transcript variants encoding different isoforms have been found for this gene.

Alternative names and synonyms associated with MET

  • met proto-oncogene (MET) antibody
  • met proto-oncogene (Met) antibody
  • met proto-oncogene (hepatocyte growth factor receptor) (MET) antibody
  • AI838057 antibody
  • AUTS9 antibody
  • c-met antibody
  • HGF antibody
  • Hgfr antibody
  • Par4 antibody
  • RCCP2 antibody

Protein level used designations for MET

HGF receptor , HGF/SF receptor , SF receptor , hepatocyte growth factor receptor , met proto-oncogene tyrosine kinase , proto-oncogene c-Met , scatter factor receptor , tyrosine-protein kinase Met , c-Met , HGF receptor c-Met

GENE ID SPECIES
4233 Homo sapiens
17295 Mus musculus
24553 Rattus norvegicus
403438 Canis lupus familiaris
280855 Bos taurus
654328 Sus scrofa
100126565 Oryctolagus cuniculus
Selected quality suppliers for anti-MET (MET) Antibodies
Did you look for something else?